945-24-4,
(2,4-diaminopteridin-6-yl)methanol,
2,4-Diamino-6-(hydroxymethyl)pteridine,
2,4-diamino-6-hydroxymethylpteridine,
6-Pteridinemethanol, 2,4-diamino-,
2,4-Diamino-6-pteridinemethanol,
UNII-1RU16O4RO0,
2,4-Diaminopteridine-6-ylmethanol,
(2,4-Diamino-6-pteridinyl)methanol,
C7H8N6O,
1RU16O4RO0,
2,4-Pteridinediamine-6-methanol,
CYNARAWTVHQHDI-UHFFFAOYSA-N,
DC329,
6-Hydroxymethyl-2,4-pteridinediamine,
GEO-00918,
SD-096950,
6-Pteridinemethanol, 2,4-diamino-, monohydrobromide,
W-200534,
NSC253944,
2,4-diamino-6-(hydroxymethyl)pteridine hydrocloride,
EINECS 213-412-2,
NSC 639363,
PubChem8650,
Methotrexate Impurity A,
AC1L2DW1,
Oprea1_073806,
SCHEMBL64019,
akos 213-118,
BIDD:GT0843,
CHEMBL78951,
CTK5H6769,
ZINC39586,
BCP09303,
CS-B0318,
KS-000002BW,
3136AH,
AN-706,
BBL027603,
CCG-40957,
MFCD00006711,
NSC639363,
STL372897,
2,4-diamino-6-hydroxymethyl pteridine,
AKOS000276916,
CHM0034690,
FCH1118844,
MCULE-3500270962,
NSC 253944,
(2,4-Diamino-6-pteridinyl)methanol #,
(2,4-Diamino-pteridin-6-yl)-methanol,
6-(hydroxymethyl)-2,4-diaminopteridine,
(2,4-diaminopteridin-6-yl)methan-1-ol,
2,4-diamino-6- (hydroxymethyl)pteridine,
AJ-08870,
AK400386,
AN-48130,
AN-51021,
SC-21369,
ST059086,
ZB001160,
DB-019871,
FT-0604579,
2,4-diamino-6-hydroxymethylpteridine, 95 %,
2,4-Diamino-6-(hydroxymethyl)pteridine, 95%,
EC 700-274-8,
I05-2954,
I14-4649,
SR-01000631064-1,
(2,4-Diaminopteridin-6-yl)methanol monohydrochloride,
(2-amino-4-imino-3,4-dihydropteridin-6-yl)methanol,
Akos 213-118;(2,4-diamino-pteridin-6-yl)-methanol,
2,4-diamino-6-hydroxymethylpteridine hydrochloride or hbr,
C7-H8-N6-O,
CID70347,
2,4-diamino-6-(hydroxymethyl)-pteridine,
73978-41-3,
57963-59-4,